References
- Palomaki O, Huhtala H, Kirkinen P. A comparative study of the safety of 0.25% levobupivacaine and 0.25% racemic bupivacaine for paracervical block in the first stage of labor. Acta Obstet Gynecol Scand 2005; 84: 956–61
- Burke D, Henderson DJ, Simpson AM, Faccenda K, Morrison L, McGrady E, et al. Comparison of 0.25% S (-) bupivacaine with 0.25% RS-bupivacaine for epidural analgesia in labour. Br J Anaesth 1999; 83: 750–5
- Convery P, Burke D, McLeod GA, Belch JJ, Mckenzce M, Bannister J, et al. Continuous infusion of levobupivacaine and bupivacaine in patients in labour – a comparison. Int J Obstet Anesth 1999; 8: 196–7
- McLeod GA, Burke D. Levobupivacaine. Anaesthesia 2001; 56: 331–41
- Kuczkowski KM. Levobupivacaine and ropivacaine: the new choices for labor analgesia. Int J Clin Pract 2004; 58: 604–5
- Gristwood RW. Cardiac and CNS toxicity of levobupivacaine: strength of evidence for advantage over bupivacaine. Drug Safety 2002; 25: 153–63
- D'Angelo R. Are the new local anesthetics worth their cost?. Acta Anaesthesiol Scand 2000; 44: 639–41